UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads

PloS one, 2013-10, Vol.8 (10), p.e77780-e77780

2013

Volltextzugriff (PDF)

Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia

Journal of virology, 2019-10, Vol.93 (20)

2019

Volltextzugriff (PDF)

HIV-Specific CD8⁺ T-Cell Immunity in Humanized Bone Marrow-Liver-Thymus Mice

The Journal of infectious diseases, 2013-11, Vol.208 (suppl_2), p.S150-S154

2013

Volltextzugriff (PDF)

Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses

Virology (New York, N.Y.), 2021-07, Vol.559, p.165-172

2021

Volltextzugriff (PDF)

IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection

Nature communications, 2015-06, Vol.6 (1), p.7562-7562, Article 7562

2015

Volltextzugriff (PDF)

Evidence for Differences in Immunologic and Pathogenesis Properties of Herpes Simplex Virus 2 Strains From the United States and South Africa

The Journal of infectious diseases, 2011-05, Vol.203 (10), p.1434-1441

2011

Volltextzugriff (PDF)

Rapid evolution of HIV-1 to functional CD8⁺ T cell responses in humanized BLT mice

Science translational medicine, 2012-07, Vol.4 (143), p.143ra98

2012

Volltextzugriff (PDF)

Disruption of the UL41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

Virology (New York, N.Y.), 2008-03, Vol.372 (1), p.165-175

2008

Volltextzugriff (PDF)

HIV-Specific CD8 super(+) T-Cell Immunity in Humanized Bone Marrow-Liver-Thymus Mice

The Journal of infectious diseases, 2013-11, Vol.208, p.S150-S154

2013

Volltextzugriff (PDF)

Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein

Vaccine, 2010-03, Vol.28 (15), p.2754-2762

2010

Volltextzugriff (PDF)

Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

Virology (New York, N.Y.), 2008-03, Vol.372 (1), p.165

2008

Volltextzugriff (PDF)

Genetic engineering of a modified herpes simplex virus 1 vaccine vector

Vaccine, 2009-05, Vol.27 (21), p.2760-2767

2009

Volltextzugriff (PDF)

Impact of NK cells on control of HIV infection in humanized BLT mice (P6207)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.118-118.27

2013

Volltextzugriff (PDF)

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs

Vaccine, 2008-07, Vol.26 (32), p.4034-4040

2008

Volltextzugriff (PDF)

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection (105.8)

The Journal of immunology (1950), 2012-05, Vol.188 (1_Supplement), p.105-105.8

2012

Volltextzugriff (PDF)

Modification of immune activation in HIV-1-infected humanized mouse model using TLR7/9 antagonists (113.19)

The Journal of immunology (1950), 2012-05, Vol.188 (1_Supplement), p.113-113.19

2012

Volltextzugriff (PDF)

BLT-humanized C57BL/6 Rag2−/−γc−/−CD47−/− mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection

Blood, 2013-12, Vol.122 (25), p.4013-4020

2013

Volltextzugriff (PDF)

Disruption of the U L 41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

Virology (New York, N.Y.), 2008, Vol.372 (1), p.165-175

2008

Volltextzugriff (PDF)

Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice

Vaccine, 2006-06, Vol.24 (24), p.5211-5219

2006

Volltextzugriff (PDF)

Disruption of the U L 41 gene in the herpes simplex virus 2 dl 5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

Virology (New York, N.Y.), 2007, Vol.372 (1), p.165-175

2007

Volltextzugriff (PDF)

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2dl5-29 anddl5-29-41L in mice and guinea pigs

Vaccine, 2008-07, Vol.26 (32), p.4034

2008

Volltextzugriff (PDF)

PD-1 Blockade in Chronically HIV-1-Infected Humanized Mice Suppresses Viral Loads: e77780

PloS one, 2013-10, Vol.8 (10)

2013

Volltextzugriff (PDF)

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl 5-29 and dl 5-29-41L in mice and guinea pigs

Vaccine, 2008, Vol.26 (32), p.4034-4040

2008

Volltextzugriff (PDF)

Studies to improve and expand the protective capacity of replication-defective type 2 herpes simplex viruses

Dudek, Timothy E

2008

Volltextzugriff (PDF)

The Ottawa Surgical Competency Operating Room Evaluation (O-SCORE): a tool to assess surgical competence

Academic medicine, 2012-10, Vol.87 (10), p.1401-1407

2012

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Englisch
(108)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads

Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia

HIV-Specific CD8⁺ T-Cell Immunity in Humanized Bone Marrow-Liver-Thymus Mice

Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses

IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection

Evidence for Differences in Immunologic and Pathogenesis Properties of Herpes Simplex Virus 2 Strains From the United States and South Africa

Rapid evolution of HIV-1 to functional CD8⁺ T cell responses in humanized BLT mice

Disruption of the UL41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

HIV-Specific CD8 super(+) T-Cell Immunity in Humanized Bone Marrow-Liver-Thymus Mice

Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein

Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

Genetic engineering of a modified herpes simplex virus 1 vaccine vector

Impact of NK cells on control of HIV infection in humanized BLT mice (P6207)

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection (105.8)

Modification of immune activation in HIV-1-infected humanized mouse model using TLR7/9 antagonists (113.19)

BLT-humanized C57BL/6 Rag2−/−γc−/−CD47−/− mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection

Disruption of the U L 41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice

Disruption of the U L 41 gene in the herpes simplex virus 2 dl 5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2dl5-29 anddl5-29-41L in mice and guinea pigs

PD-1 Blockade in Chronically HIV-1-Infected Humanized Mice Suppresses Viral Loads: e77780

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl 5-29 and dl 5-29-41L in mice and guinea pigs

Studies to improve and expand the protective capacity of replication-defective type 2 herpes simplex viruses

The Ottawa Surgical Competency Operating Room Evaluation (O-SCORE): a tool to assess surgical competence

Suchergebnisse filtern